Compare FUBO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUBO | ETON |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.3M | 683.7M |
| IPO Year | 2011 | 2018 |
| Metric | FUBO | ETON |
|---|---|---|
| Price | $12.49 | $24.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $28.40 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 4.7M | 471.3K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.08 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,271,000.00 | ★ $79,950,000.00 |
| Revenue This Year | $45.37 | $40.90 |
| Revenue Next Year | $6.47 | $47.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10317.07 | 104.94 |
| 52 Week Low | $1.02 | $13.09 |
| 52 Week High | $14.21 | $27.29 |
| Indicator | FUBO | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 56.50 |
| Support Level | $3.17 | $16.38 |
| Resistance Level | $14.05 | N/A |
| Average True Range (ATR) | 1.07 | 1.20 |
| MACD | 0.05 | -0.12 |
| Stochastic Oscillator | 74.87 | 48.01 |
FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.